Overall Survival in Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes

This meta-analysis of randomized clinical trials assesses overall survival in men with bone metastases from castration-resistant prostate cancer treated with bone-targeted radioisotopes and compares the effects of α-emitting with β-emitting radioisotopes.

Read the full article here

Related Articles